Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications

Elina Alaterre, Nicolas Robert, Guilhem Requirand, Amélie Machura, Hugues De Boussac, Laure Vincent, Charles Herbaux, Angélique Bruyer, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 4743.

https://doi.org/10.1182/blood-2023-181767

Published: 2023

Journal Articles

Characterization of a New Metabolic Score Correlated with CD38 Cell-Surface Expression and Response to Daratumumab Treatment in Multiple Myeloma

Alizée Steer, Elina Alaterre, Djamila Chamlal, Emmanuel Varlet, Amélie Machura, Alboukadel Kassambara, Guilhem Requirand, Nicolas Robert, Laure Vincent, Charles Herbaux, Hugues De Boussac, Angélique Bruyer, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 1949.

https://doi.org/10.1182/blood-2023-180877

Published: 2023

Journal Articles

Lipid-Mediated Modulation of DNA Damage Signaling As a Prognostic and Therapeutic Strategy Against Multiple Myeloma

Elvira Garcia De Paco, Caroline Soulet, Guilhem Requirand, Nicolas Robert, Guillaume Cartron, Laure Vincent, Charles Herbaux, Maria Moriel-Carretero, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 3322.

https://doi.org/10.1182/blood-2023-181039

Published: 2023

Journal Articles

Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

Laure Dutrieux, Elle Loughran, Armelle Choquet, Hélène Herault, Antoine Guillemin, Nicolas Robert, Guilhem Requirand, Guillaume Cartron, Laure Vincent, Charles Herbaux, Eric Rivals, Alexandre David, Jerome Moreaux

Blood (2023) 142 (Supplement 1): 1924.

https://doi.org/10.1182/blood-2023-184749

Published: 2023

Journal Articles

Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Sara ovejero-Merino, Julie Devin, Tatiana Cañeque, Laura Alibert, Guilhem Requirand, Nicolas Robert, Alizée Steer, Amelie Machura, Christophe Hirtz, Angélique Bruyer, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Caroline Bret, Jerome Moreaux

Blood (2022) 140 (Supplement 1): 9980–9981.

https://doi.org/10.1182/blood-2022-163252

Published: 2022

Journal Articles

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

Sara ovejero-Merino, Laura Alibert, Julie Devin, Tatiana Cañeque, Ouissem Karmous Gadacha, Matthieu Abouladze, Guilhem Requirand, Nicolas Robert, Hugues De Boussac, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Jerome Moreaux, Caroline Bret

Blood (2022) 140 (Supplement 1): 6439–6440.

https://doi.org/10.1182/blood-2022-164644

Published: 2022

Journal Articles

EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma

Djamila Chemlal, Emmanuel Varlet, Amelie Machura, Guilhem Requirand, Nicolas Robert, Elina Alaterre, Laure Vincent, Charles Herbaux, Giacomo Cavalli, Angélique Bruyer, Hugues De Boussac, Jerome Moreaux

Blood (2022) 140 (Supplement 1): 4220–4221.

https://doi.org/10.1182/blood-2022-163261

Published: 2022

Journal Articles

Genomic Characterization of in Vitro Acquired-Resistance to Proteasome Inhibitors

Hugues De Boussac, Alboukadel Kassambara, Amelie Machura, Djamila Chemlal, Claire Gourzones, Guilhem Requirand, Nicolas Robert, Laure Vincent, Charles Herbaux, Angélique Bruyer, Jerome Moreaux

Blood (2021) 138 (Supplement 1): 2651.

https://doi.org/10.1182/blood-2021-148584

Published: 2021

Journal Articles

Exploiting Transcription-Replication Conflicts As a Novel Therapeutic Intervention in Multiple Myeloma

Laure Dutrieux, Yea-Lih Lin, Malik Lutzmann, Guilhem Requirand, Nicolas Robert, Laure Vincent, Guillaume Cartron, Charles Herbaux, Raphael Rodriguez, Michel Cogne, Philippe Pasero, Jerome Moreaux

Blood (2021) 138 (Supplement 1): 1582.

https://doi.org/10.1182/blood-2021-151530

Published: 2021

Journal Articles

Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma

Elina Alaterre, PhD, Laurie Herviou, Hugues De Boussac, PhD, Giorgio Papadopoulos, PhD, Stéphanie Boireau, Nicolas Robert, Guilhem Requirand, Angelique Bruyer, Sara Ovejero-Merino, PhD, Laure Vincent, Anne Marie Martinez, Giacomo Cavalli, PhD, Jerome Moreaux, PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-138801

Published: 2020

Journal Articles

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Angélique Bruyer, MSc, Nicolas Robert, Stéphanie Boireau, Christophe Hirtz, Laurent Tiers, Laure Vincent, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Bernard Klein, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 3045.

https://doi.org/10.1182/blood.V130.Suppl_1.3045.3045

Published: 2017

Journal Articles

Combined Inhibition of Chk1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients

Angelique Bruyer, Hugues de Boussac, PhD, Thibaut Martin, Alboukadel Kassambara, PhD, Nicolas Robert, Guillaume Cartron, Dirk Hose, MD, Anja Seckinger, Philippe Pasero, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1777.

https://doi.org/10.1182/blood.V130.Suppl_1.1777.1777

Published: 2017

Journal Articles

Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets

Hugues de Boussac, PhD, Angelique Bruyer, Nicolas Robert, Anke Maes, Laure Vincent, Anja Seckinger, Guillaume Cartron, Dirk Hose, MD, Elke De Bruyne, PhD, Alboukadel Kassambara, PhD, Jerome Moreaux, PhD

Blood (2017) 130 (Supplement 1): 1766.

https://doi.org/10.1182/blood.V130.Suppl_1.1766.1766

Published: 2017

Journal Articles

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

Angelique Bruyer, Alboukadel Kassambara, PhD, Paul Anziani, Donia El Bahlagui, Nicolas Robert, Laure Vincent, MD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 5666.

https://doi.org/10.1182/blood.V128.22.5666.5666

Published: 2016

Journal Articles

Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

Laurie Herviou, Alboukadel Kassambara, PhD, Stephanie Boireau, PhD, Nicolas Robert, Guilhem Requirand, Laure Vincent, MD, Anja Seckinger, MD, Hartmut Goldschmidt, MD, Dirk Hose, MD, Giacomo Cavalli, PhD, Jerome Moreaux, PhD

Blood (2016) 128 (22): 311.

https://doi.org/10.1182/blood.V128.22.311.311

Published: 2016

Journal Articles

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

Alboukadel Kassambara, PhD, Angelique Bruyer, Michel Jourdan, Nicolas Robert, Véronique Pantesco, Olivier Elemento, PhD, Bernard Klein, Jerome Moreaux, PhD

Blood (2016) 128 (22): 2069.

https://doi.org/10.1182/blood.V128.22.2069.2069

Published: 2016

Journal Articles

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Jerome Moreaux, PhD, Anne-Catherine Sprynski, Karene Mahtouk, PhD, Philippe Moine, Nicolas Robert, Jean-François Rossi, MD, PhD, Bernard Klein, PhD

Blood (2007) 110 (11): 3522.

https://doi.org/10.1182/blood.V110.11.3522.3522

Published: 2007

Journal Articles

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

Michel Jourdan, PhD, Jerome Moreaux, PhD, Dirk Hose, MD, Jean-Francois Rossi, MD, PhD, Karène Mahtouk, PhD, Mathieu Aboulaze, Nicolas Robert, Marion Baudard, MD, PhD, Thierry Reme, MD, PhD, Angela Romanelli, Hartmut Goldschmidt, MD, Michel Dreano, PhD, Bernard Klein, MD, PhD

Blood (2006) 108 (11): 3472.

https://doi.org/10.1182/blood.V108.11.3472.3472

Published: 2006

Journal Articles

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Jerome Moreaux, Friedrich W. Cremer, Thierry Reme, Karene Mahtouk, Veronique Pantesco, John de Vos, Marion Moos, Nicolas Robert, Hartmut Goldschmidt, Jean-François Rossi, Dirk Hose, Bernard Klein

Blood (2005) 106 (11): 3400.

https://doi.org/10.1182/blood.V106.11.3400.3400

Published: 2005

NARROW

Integrative Multi-Omics Analysis of Tumor-Immune Microenvironment in Multiple Myeloma: Novel Insights and Therapeutic Implications

Characterization of a New Metabolic Score Correlated with CD38 Cell-Surface Expression and Response to Daratumumab Treatment in Multiple Myeloma

Lipid-Mediated Modulation of DNA Damage Signaling As a Prognostic and Therapeutic Strategy Against Multiple Myeloma

Translation Inhibition through eIF4A1 Targeting in Multiple Myeloma Is a Promising Therapeutic Strategy

Targeting Iron Homeostasis As a Therapeutic Strategy in Multiple Myeloma

Ironomycin Induces Mantle Cell Lymphoma Cell Death By Targeting Iron Metabolism Addiction

EZH2 Targeting Induces CD38 Upregulation and Response to Anti-CD38 Antibodies in Multiple Myeloma

Genomic Characterization of in Vitro Acquired-Resistance to Proteasome Inhibitors

Exploiting Transcription-Replication Conflicts As a Novel Therapeutic Intervention in Multiple Myeloma

Comprehensive Characterization of the Epigenetic Landscape in Multiple Myeloma

CD200 Is a Potent New Growth Factor in Multiple Myeloma through IGF-1R Interaction

Combined Inhibition of Chk1 and Wee1 As a New Therapeutic Strategy for High-Risk Multiple Myeloma Patients

Kinome Expression Profiling in Multiple Myeloma Identifies New Therapeutic Targets

Identification of a Gene Signature Associated to Treatment Response to Palbociclib in Multiple Myeloma

Targeting EZH2 in Multiple Myeloma Could be Promising for a Subgroup of MM Patients in Combination with IMiDs

Patterns of Microrna in Plasma Cells: From Normal Differentiation to Multiple Myeloma

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.

Inhibition of Multiple Myeloma Cells Growth by AS602868, a Pharmacological Inhibitor of IKK2.

TACI and BCMA, Unlike BAFF-R, Are Expressed by Human Myeloma Cell Lines and TACI + Cell Lines Have a Gene Signature Indicative of Mature Bone Marrow Plasma Cells and Bone Marrow Environment Dependence.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only